Swedish oncology firm Elekta of Stockholm reports that demand for its clinical products and services remained strong in the first three months of fiscal year 2010 (end-July 31).
Net sales increased 15% to 1.44 billion kronor ($201 million U.S.), compared with 1.3 billion kronor ($153.7 million U.S.) in the first quarter of fiscal 2009. Operating profit rose to 89 million kronor ($12.4 million U.S.).
Elekta also noted that its efficiency improvement program is proceeding as planned. Restructuring costs totaled 11 million kronor ($1.5 million U.S.) in the first fiscal quarter. Annual savings from the program are expected to be 100 million kronor ($14 million U.S.) with the full effect in the next fiscal year.
Elekta also held to its financial outlook for net sales growth of more than 8% and operating profit of more than 35% in fiscal 2010.
Related Reading
Elekta takes Czech software order, September 4, 2009
Elekta taps new North American head, September 3, 2009
Elekta scores Brazilian order, August 14, 2009
Elekta nets U.S. orders, August 12, 2009
Elekta nets FDA OK for VMAT, July 24, 2009
Copyright © 2009 AuntMinnie.com
